Submitted by Constance, Vascular Access Coordinator, Provena Saint Joseph Hospital on Thu Mar 11 18:39:52 2010

As anyone gone to the DeRoyal Silver Alginate disk from the Bipatch? I am told that costs less than the Biopatch. Any thoughts or comments?

Thanks

Connie

‹ Interventional radiology techs placing PICC lines Photos in the medical record ›
Thu, 03/11/2010 - 22:24 — kathykokotis

royal

There are no prospective, randomized, blinded studies to my knowlegge on the Royal product

The Biopatch that I do not represent has a meta-analysis of randomized, prospective, blinded studies in JAMA done in 2009.  In other words there are more than one study on biopatch therefore meta-analysis

The Biopatch does have a marketing indication from the FDA to reduce infection. and organism colinization if I am not mistaken  I am not sure the Royal product has this indication.  Many of the devices have indications for securement only and not infection reduction.  I would read their instructions for use (IFU's) as that is what has gone thru the FDA for claims.  The claims will be based on any studies and testing they submitted to the FDA.

I personally do not endorse any product. 

Hope that helps

Kathy Kokotis RN BD MBA

Bard Access Systems

 
For documents, software, and forum discussions available from this or referred servers, the IV Therapy web site does not warrant or assume any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed. Those who contribute do so only to share their opinions and suggestions. They and the owners of this site are not liable for the accuracy of those opinions or suggestions.